MindLIFT Treatment in Milwaukee, WI
Introducing MindLIFT – A New Horizon in Mental Health Treatment
At Edelica Health, we have always been at the forefront of interventional mental health treatments. Continuing our legacy of innovative care, we are thrilled to introduce MindLIFT – a groundbreaking neuromodulator injection therapy designed for individuals battling depression, bipolar disorder, and borderline personality disorder. This unique approach represents a significant advancement in mental health treatment, offering new hope and possibilities for our patients.
What is MindLIFT?
MindLIFT utilizes neuromodulators, such as Botox and Dysport, which are widely recognized for their aesthetic applications. However, their benefits extend far beyond cosmetics. Since 1989, neuromodulators have been used to treat various medical conditions, including urinary incontinence, spasticity, and chronic migraines. Recent studies have illuminated their potential in effectively treating depression by targeting specific facial muscles.
The Science Behind MindLIFT
The efficacy of MindLIFT is grounded in the “Facial Feedback Hypothesis,” which posits that our emotions are intricately linked with our facial expressions. The brain processes signals from muscles involved in smiling and frowning to gauge mood. MindLIFT focuses on relaxing the muscles associated with frowning, thereby reducing negative emotional feedback and fostering a more positive mood.
Clinical Evidence Supporting MindLIFT
Robust clinical research underpins the MindLIFT approach. Several randomized controlled trials have demonstrated that neuromodulator injections to relax frown muscles can safely and effectively alleviate symptoms of depression. A comprehensive analysis of five studies revealed a substantial reduction in depressive symptoms, with an average improvement rate of 47%. These results are on par with those of traditional antidepressants, like Citalopram, but with fewer severe side effects.
Neurotransmitters, Brain Activity, and MindLIFT
Intriguingly, research involving neuromodulator injections in mice indicated a rise in neurotransmitters and growth factors in the brain, suggesting a neurobiological basis for the treatment’s effectiveness. Furthermore, functional MRI studies have shown that these injections can calm activity in the amygdala, a key emotional center in the brain. Since heightened amygdala activity is a characteristic of depression, normalizing this overactivity through MindLIFT could lessen intense negative emotions.
Treatment Duration and Efficacy
A single MindLIFT treatment is anticipated to provide relief for three to four months. This duration aligns with the lifecycle of neuromodulator effects, ensuring sustained benefits for our patients.
MindLIFT is suitable for a diverse range of patients, including:
- Individuals with chronic depression or bipolar disorder.
- Patients displaying emotional lability.
- Those with agitated depression.
- People diagnosed with borderline personality disorder. A small case study indicated a 49-94% reduction in Borderline PD symptoms following Botox treatment.
The MindLIFT Procedure: What to Expect
The MindLIFT procedure is straightforward and minimally invasive. During the treatment, a small amount of neuromodulator is injected into targeted areas of the forehead. The process is quick, with minimal discomfort, and patients can typically resume their regular activities immediately after the session.
Cost and Accessibility of MindLIFT
We believe in transparent and accessible mental health care. The cost of MindLIFT varies depending on the medication amount and type (Botox or Dysport). Generally, the price is approximately $250 for women and $330 for men, accounting for the difference in muscle thickness. It is important to note that this treatment is not covered by insurance.
A Step Toward Healing and Recovery
MindLIFT at Edelica Health is more than just a treatment; it’s a journey towards a brighter, more stable future. By addressing mental health challenges with this innovative approach, we open doors to new possibilities for wellness and recovery.
If you or someone you know is struggling with depression, bipolar disorder, or borderline personality disorder, MindLIFT might be the right step forward. Our team at Edelica Health is ready to guide you through every step of this journey. To learn more about MindLIFT or to schedule a consultation, please contact us at 414-441-5707. Embrace the opportunity for a positive change in your life with MindLIFT at Edelica Health.
Request Your Consultation Today
Scientific References
- Botulinum toxin: Emerging psychiatric indications. Junghyun Kim, MD Rita Khoury, MD, George T. Grossberg, MD. Current Psychiatry. 2018 December;17(12):8-18
- Anti-depressant-Like Action of Single Facial Injection of Botulinum Neurotoxin A… Li Et Al. Neurosci Bull. 2019 Mar 21. [Epub ahead of print]
- Botulinum toxin-induced facial muscle paralysis affects amygdala responses to the perception of emotional expressions… Kim et al. Biology of Mood &Anxiety Disorders 2014, 4:11
- Facing depression with botulinum toxin: a randomized controlled trial. Wollmer MA, De Boer C, Kalak N, et al. J Psychiatr Res. 2012;46:574-581.
- Treatment of depression with onabotulinumtoxinA; a randomized, double-blind, placebo controlled trial. Finzi E, Rosenthal NE. J Psychiatr Res. 2014;52:1-6.
- The treatment of major depressive disorder using botulinum toxin A: a 24 week randomized, double-blind, placebo-controlled study.. Magid M, Reichenberg JS, Poth PE, et al. J Clin Psychiatry. 2014;75(8):837-844.
- Efficacy of botox versus placebo for treatment of patients with Major Depression. Zamanian A, Ghanbari Jolfaei A, Mehran G, et al. Iran J Public Health. 46(7):982-984.
- Botulinum toxin for depression: Does patient appearance matter? Rechenberg JS, Hauptman AJ, Robertson HT, et al. J Am Acad Dermatol. 2016;74(1):171-173.
- Treating depression with botulinum toxin: a pooled analysis of randomized controlled trials. Magid M, Finzi E, Kruger THC, et al. Pharmacopsychiatry. 2015;48(6): 205-210.
- Botulinum toxin as a treatment for depression in a real-world setting. Chugh S, Chhabria A, Jung S, et al. J Psychiatr Pract. 2018;24(1):15-20.
- Can botulinum toxin help patients with borderline personality disorder? Kruger TH, Magid M, Wollmer MA. Am J Psychiatry. 2016;173(9):940-941.
- Deeper than skin deep – the effect of botulinum toxin-A on emotion processing. Baumeister JC, Papa G, Foroni F. Toxicon. 2016;119:86-90.
- Agitation predicts response of depression to botulinum toxin treatment in a randomized controlled trial. Wollmer, MA, et al.. Frontiers in Psychiatry. Mar 2014.
- Glabellar Botulinum Toxin Injection Improves Depression Scores: A Systematic Review and Meta-Analysis. Crowley, Jiwon,s.; Milverstein, Max L., et al.; Plastic and Reconstructive Surgery, 29 Jun 2022; Vol 150(1):211e-221e
- Botulinum Toxin and its Effect on Depression. Guvenc U. EJMI 2023;7(4):477–481.
- Botulinum Toxin Therapy for Psychiatric Disorders in Clinical Practice: A Retrospective Case Study. Lehnert, F.; Neumann, I.; Krüger, T.H.C.; Wollmer, M.A Toxins2023,15,385.
- Neurocircuitry underlying the antidepressant effect of retrograde facial botulinum toxin in mice. Ni et al. Cell & Bioscience (2023) 13:30
Request A Consultation